Literature DB >> 9017568

What happens when a demonstration project ends. Consequences for a clinic and its clients.

C E Grella1, M D Anglin, R Rawson, R Crowley, A Hasson.   

Abstract

The Los Angeles Enhanced Methadone Maintenance Project was a 5-year research demonstration project funded by the National Institute on Drug Abuse with the goal of reducing high-risk behavior for human immunodeficiency virus (HIV) among heroin users. A clinic was established for the purposes of the study and 500 clients with high-risk profiles were recruited into treatment. Follow-up assessments demonstrated that clients had reduced their drug use, criminal behavior, and HIV-risk behaviors after entering treatment. At the end of the project clients were given the option of continuing treatment at the clinic on a fee-for-service basis, transferring to another treatment provider, or undergoing detoxification. Clients who were eligible for Medicaid were likely to continue receiving methadone treatment, but those without Medicaid funding were not. The implications of terminating treatment among a high-risk population recruited into a research demonstration project are discussed.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9017568     DOI: 10.1016/s0740-5472(96)00055-4

Source DB:  PubMed          Journal:  J Subst Abuse Treat        ISSN: 0740-5472


  3 in total

1.  Longitudinal effects of LAAM and methadone maintenance on heroin addict behavior.

Authors:  M Douglas Anglin; Bradley T Conner; Jeffrey J Annon; Douglas Longshore
Journal:  J Behav Health Serv Res       Date:  2008-11-21       Impact factor: 1.505

Review 2.  Brief report: Methadone treatment of injecting opioid users for prevention of HIV infection.

Authors:  Linda R Gowing; Michael Farrell; Reinhard Bornemann; Lynn E Sullivan; Robert L Ali
Journal:  J Gen Intern Med       Date:  2005-12-07       Impact factor: 5.128

3.  Retention in publicly funded methadone maintenance treatment in two Western States.

Authors:  Dennis Deck; Matthew J Carlson
Journal:  J Behav Health Serv Res       Date:  2005 Jan-Mar       Impact factor: 1.505

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.